Zebrafish Model: Worth Considering in Defining Tumor Angiogenesis

Trends in Cardiovascular Medicine

Volumn 20, Issue 4, 2010, Pages 114-119

  Moshal, Karni S ^a   Ferri Lagneau, Karine F ^a   Leung, TinChung ^a  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; HUMAN; INFLAMMATION; METASTASIS; MOLECULARLY TARGETED THERAPY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ZEBRA FISH;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; DISEASE MODELS, ANIMAL; INFLAMMATION; NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

EID: 79951532240     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.10.001     Document Type: Review

References (46)

1. Basile J.R., Holmbeck K., Bugge T.H., Gutkind J.S. MT1-MMP controls tumor induced angiogenesis through the release of semaphorin 4D. J Biol Chem 2007, 282:6899-6905.
2. Bottaro D.P., Liotta L.A. Cancer: out of air is not out of action. Nature 2003, 423:593-595.
3. Ebos J.M., Lee C.R., Cruz-Munoz W., et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15:232-239.
4. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001, 280:C1358-C1366.
5. Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5:1359-1364.
6. Ferrara N., Hillan K.J., Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 2005, 333:328-335.
7. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997, 173:206-210.
8. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29:15-18.
9. Haldi M., Ton C., Seng W.L., McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006, 9:139-151.
10. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
11. Hidetaka N., Hideharu F., Hidetoshi Y., et al. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Arch Ophthalmol 2002, 120:1075-1080.
12. Hooper A.T., Shmelkov S.V., Gupta S., et al. Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis. Circ Res 2009, 105:201-208.
13. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
14. Jain R.K. Vascular and interstitial biology of tumors. Clinical Oncology 2004, 153-172. Elsevier, Philadelphia, PA. 3rd edition. M. Abeloff (Ed.).
15. Jain R.K. Normalization of tumor vasculature: an emerging concept in anti-angiogenic therapy. Science 2005, 307:58-62.
16. Kent D., Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis 2003, 9:747-755.
17. Kim S., Takahashi H., Lin W.W., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
18. Krikun G., Schatz F., Lockwood C.J. Endometrial angiogenesis: from physiology to pathology. Ann N Y Acad Sci 2004, 1034:27-35.
19. Lee L.M., Seftor E.A., Bonde G., et al. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005, 233:1560-1570.
20. Lee S.L., Rouhi P., Dahl Jensen L., et al. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A 2009, 106:19485-19490.
21. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
22. Leung T., Chen H., Stauffer A.M., et al. Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis. Blood 2006, 108:160-166.
23. Ma J., Pulfer S., Li S., et al. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 2001, 61:5491-5498.
24. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457:36-37.
25. Marques I.J., Weiss F.U., Vlecken D.H., et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9:128.
26. Miao Z., Luker K.E., Summers B.C., et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A 2007, 104:15735-15740.
27. Miller K., Wang M., Gralow J., et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007, 357:2666-2676.
28. Mizgireuv I.V., Revskoy S.Y. Transplantable tumor lines generated in clonal zebrafish. Cancer Res 2006, 66:3120-3125.
29. Mizgireuv I., Revskoy S. Generation of clonal zebrafish lines and transplantable hepatic tumors. Nat Protoc 2010, 5:383-394.
30. Moehler T.M., Neben K., Ho A.D., Goldschmidt H. Angiogenesis in hematologic malignancies. Ann Hematol 2001, 80:695-705.
31. Motzer R.J., Michaelson M.D., Redman B.G., et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 2006, 24:16-24.
32. Murphy E.A., Shields D.J., Stoletov K., et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF. Proc Natl Acad Sci U S A 2010, 107:4299-4304.
33. Nicoli S., Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2007, 11:2918-2923.
34. Nicoli S., Ribatti D., Cotelli F., Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007, 67:2927-2931.
35. Padera T.P., Stoll B.R., Tooredman J.B., et al. Pathology: cancer cells compress intratumour vessels. Nature 2004, 427:695.
36. Pàez-Ribes M., Allen E., Hudock J., et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231.
37. Rosen L. Antiangiogenic strategies and agents in clinical trials. Oncologist 2000, 5:20-27.
38. Stoletov K., Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008, 27:4509-4520.
39. Stoletov K., Montel V., Lester R.D., et al. High-resolution imaging of the dynamic tumor cell-vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007, 104:17406-17411.
40. Thijssen V.L., Postel R., Brandwijk R.J., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 2006, 103:15975-15980.
41. Topczewska J.M., Postovit L.M., Margaryan N.V., et al. Embryonic and tumorigenic pathways converge via nodal signaling: role in melanoma aggressiveness. Nat Med 2006, 12:925-932.
42. Vignola A.M., Mirabella F., Costanzo G., et al. Airway remodeling in asthma. Chest 2003, 123:417S-422S.
43. Vlecken D.H., Bagowski C.P. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells. Zebrafish 2009, 6:433-439.
44. Voros G., Maquoi E., Demeulemeester D., et al. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005, 146:4545-4554.
45. White R.M., Sessa A., Burke C., et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2:183-189.
46. Winkler F., Kozin S.V., Tong R.T., et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004, 6:553-563.